Literature DB >> 12068142

The clinical significance of a pathergy reaction in patients with Behcet's disease.

Hyun Kyu Chang1, Kyeong Soo Cheon.   

Abstract

This study was done to evaluate the frequency, intensity, and specificity of a positive pathergy reaction (PR) in Behcet's disease (BD) patients, to clarify an association between the PR and the clinical features or disease severity, and to assess whether patients with pustule formation at the venous puncture site (PFVPS) without positive PR could be regarded as a positive reaction. The PR was tested in 64 BD patients, 74 disease controls, and 20 healthy controls. Venous PR was performed in 8 BD patients with PFVPS. Follow-up PR was done in 14 patients with positive reaction during inactive phase. The PR was positive in 35.9% of BD patients, in 1 patient among disease controls, and in none of healthy controls. The pustule formation was observed in one BD patient. There was no statistical significance between positive PR and the clinical variables. The mean clinical activity score of BD patients with positive PR was similar to patients with negative reaction. Venous PR was positive in 7 patients. The follow-up PR was positive in 2 patients during inactive phase. Conclusively the positive PR appeared to be specific for BD, and was not associated with the clinical variables or disease severity, but was usually found during active phase in cases with positive reaction. The PFVPS in patients with negative PR might be considered to be positive.

Entities:  

Mesh:

Year:  2002        PMID: 12068142      PMCID: PMC3054891          DOI: 10.3346/jkms.2002.17.3.371

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  17 in total

1.  Decreased protein S activity is related to the disease activity of Behcet's disease.

Authors:  Seong Ryul Kwon; Mie Jin Lim; Shin Goo Park; Yeon Sook Moon; Won Park
Journal:  Rheumatol Int       Date:  2006-09-13       Impact factor: 2.631

Review 2.  The unique features of vasculitis in Behçet's syndrome.

Authors:  Melike Melikoglu; Emire Kural-Seyahi; Koray Tascilar; Hasan Yazici
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

Review 3.  Clinical Immunology Review Series: an approach to the patient with recurrent orogenital ulceration, including Behçet's syndrome.

Authors:  M T Keogan
Journal:  Clin Exp Immunol       Date:  2008-12-11       Impact factor: 4.330

4.  Evaluation of pathergy test positivity in familial Mediterranean fever patients and comparison of clinical manifestations of FMF with Behçet's disease.

Authors:  Fatma Aydin; Tekin Akpolat; Nilgun Senturk; Hasan Bagci; Ahmet Yasar Turanli
Journal:  Clin Rheumatol       Date:  2009-07-29       Impact factor: 2.980

5.  Leukopenia predicts remission in patients with inflammatory bowel disease and Behcet's disease on thiopurine maintenance.

Authors:  Mi Sung Park; Dong Hyun Kim; Duk Hwan Kim; Soo Jung Park; Sung Pil Hong; Tae Il Kim; Won Ho Kim; Jae Hee Cheon
Journal:  Dig Dis Sci       Date:  2014-09-20       Impact factor: 3.199

6.  The natural course and factors affecting severity of Behçet's disease: a single-center cohort of 368 patients.

Authors:  Nilay Ugurlu; Selen Bozkurt; Ali Bacanli; Ayse Akman-Karakas; Soner Uzun; Erkan Alpsoy
Journal:  Rheumatol Int       Date:  2015-06-18       Impact factor: 2.631

7.  Faraway from the silk route: demographic and clinical features of Behçet's disease in 106 Brazilian patients.

Authors:  Fabricio Souza Neves; Cezar Augusto Muniz Caldas; Laís Verderame Lage; Cláudia Goldenstein-Schainberg; Célio Roberto Gonçalves
Journal:  Clin Rheumatol       Date:  2009-01-13       Impact factor: 2.980

8.  Comparison of argon laser photocoagulation-induced cutaneous inflammation and skin pathergy test in Behçet's disease.

Authors:  Mehmet Sayarlioglu; Omer Calka; Adnan Cinal; Hayriye Sayarlioglu; Necmeddin Akdeniz; Nazan Topcu; Arzu Cevik Durmus; Ahmet Demirok; Baranbari Ilhan; Ahmet Gul
Journal:  Clin Rheumatol       Date:  2009-10-11       Impact factor: 2.980

9.  Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease and rheumatic diseases with vasculitis.

Authors:  J U Kim; H K Chang; S S Lee; J W Kim; K T Kim; S W Lee; W T Chung
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

10.  Managing Behçet's disease: An update on current and emerging treatment options.

Authors:  P La van Daele; J H Kappen; P M van Hagen; J Am van Laar
Journal:  Ther Clin Risk Manag       Date:  2009-05-20       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.